Cargando…

The genomic dynamics during progression of lung adenocarcinomas

Intra-tumor heterogeneity is a big barrier to precision medicine. To explore the underlying clonal diversity in lung adenocarcinomas, we selected nine individuals with whole-genome sequencing data from primary and matched metastatic tumors as a cohort for study. Similar global pattern of arm-level c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Bin, Luo, Longhai, Luo, Wen, Zhou, Yong, Yang, Chao, Xiong, Teng, Li, Xiangchun, Meng, Xuan, Li, Lin, Zhang, Xiaopin, Wang, Zhe, Wang, Zhixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537414/ https://www.ncbi.nlm.nih.gov/pubmed/28381877 http://dx.doi.org/10.1038/jhg.2017.40

Ejemplares similares

Evaluation of dynamic image progression of minimally invasive and preinvasive lung adenocarcinomas
por: Chen, Tianxiang, et al.
Publicado: (2021)

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
por: Wang, Qinghua, et al.
Publicado: (2020)

An esophageal squamous cell carcinoma classification system that reveals potential targets for therapy
por: Xiong, Teng, et al.
Publicado: (2017)

Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway
por: Shang, Bin, et al.
Publicado: (2021)

Spatial transcriptomics delineates molecular features and cellular plasticity in lung adenocarcinoma progression
por: Wang, Yan, et al.
Publicado: (2023)

Silencing circUSP48 suppresses osteosarcoma progression by regulating the miR‐335/ smad nuclear interacting protein 1 pathway
por: Luo, Yue, et al.
Publicado: (2023)

Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma
por: Wang, XiaoFang, et al.
Publicado: (2023)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Upregulation of CENPM facilitates lung adenocarcinoma progression via PI3K/AKT/mTOR signaling pathway: CENPM promotes lung adenocarcinoma progression
por: Liu, Chao, et al.
Publicado: (2021)

The landscape of somatic mutation in sporadic Chinese colorectal cancer
por: Liu, Zhe, et al.
Publicado: (2018)

ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression
por: Qu, Tongyuan, et al.
Publicado: (2020)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma
por: Luo, Xuan, et al.
Publicado: (2021)

Suppression of CCT3 Inhibits Tumor Progression by Impairing ATP Production and Cytoplasmic Translation in Lung Adenocarcinoma
por: Chen, Shuohua, et al.
Publicado: (2022)

Whole-Genome Sequence of Streptococcus parauberis Strain SP-llh, Isolated from Cows with Mastitis in Western China
por: Liu, Longhai, et al.
Publicado: (2017)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

A Novel Immune-Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2022)

The expression and prognostic value of disulfidptosis progress in lung adenocarcinoma
por: Ni, Lina, et al.
Publicado: (2023)

Single-cell RNA sequencing reveals the cellular and molecular changes that contribute to the progression of lung adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2022)

XBP1 impacts lung adenocarcinoma progression by promoting plasma cell adaptation to the tumor microenvironment
por: Zhong, Zhaoqian, et al.
Publicado: (2022)

TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect
por: Xing, Yutong, et al.
Publicado: (2020)

Bioinformatics Identification of Key Genes for the Development and Prognosis of Lung Adenocarcinoma
por: Luo, Xuan, et al.
Publicado: (2022)

Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1
por: Li, Jianjun, et al.
Publicado: (2022)

VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma
por: Zhang, Lihua, et al.
Publicado: (2020)

AGTR1 Inhibits the Progression of Lung Adenocarcinoma
por: Xiong, Lecai, et al.
Publicado: (2021)

A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma
por: Wang, Xuelong, et al.
Publicado: (2021)

Solasonine Causes Redox Imbalance and Mitochondrial Oxidative Stress of Ferroptosis in Lung Adenocarcinoma
por: Zeng, Yao-Ying, et al.
Publicado: (2022)

Nicotine Induces Progressive Properties of Lung Adenocarcinoma A549 Cells by Inhibiting Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Plasma Membrane Localization
por: Li, Hui, et al.
Publicado: (2018)

UPP1 Promotes Lung Adenocarcinoma Progression through Epigenetic Regulation of Glycolysis
por: Wang, Xuan, et al.
Publicado: (2022)

Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry
por: Li, Yan, et al.
Publicado: (2013)

Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression
por: Li, Hongxia, et al.
Publicado: (2020)

The application of CGF combined with GBR in alveolar bone increment for patients with anxiety disorder: A rare case report and literature review
por: Li, Zhixin, et al.
Publicado: (2023)

Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023)

Molecular features of lung adenocarcinoma in young patients
por: Chen, Zhen, et al.
Publicado: (2019)

Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma
por: Feng, Alei, et al.
Publicado: (2022)

Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy
por: Xu, Feng, et al.
Publicado: (2020)

Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements
por: Zhang, Yongchang, et al.
Publicado: (2022)

Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023)

The dynamic dysregulated network identifies stage-specific markers during lung adenocarcinoma malignant progression and metastasis
por: Wang, Li, et al.
Publicado: (2022)

The interplay between ATF2 and NEAT1 contributes to lung adenocarcinoma progression
por: Liu, Jian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b1j3fksblnvvhp7e4ojnupoea0